logo

For the Inventor, By the Inventor

Barcelona, Spain

Cristina Carreño Serraïma

This inventor holds 15 USPTO granted patents and 5 published patent applications and 9 EPO patents. Top assignees: Lipotec, S.a., Lubrizol Advanced Materials, Inc., Bcn Peptides S.a.. Active years: 2007-2017.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Cristina Carreño Serraïma. Retrieved from https://idiyas.com/inventor/cristina-carreno-serraima

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 15 

% Patents Active = 93.3

 

Average Co-Inventor Count = 5.6

ph-index = 7

Forward Citations = 136(Granted Patents)


Location History:

  • Gavá-Barcelona, ES (2016)
  • Barcelona, ES (2007 - 2017)

Company Filing History:

goldMedal8 out of 31 
 
Lipotec, S.a.
 patents
silverMedal4 out of 237 
 
Lubrizol Advanced Materials, Inc.
 patents
bronzeMedal2 out of 8 
 
Bcn Peptides S.a.
 patents
4. 2 out of 3 
 
Diverdrugs, S.l
 patents
5. 1 out of 2 
 
Lipotech, S.a.
 patents
6. 1 out of 1 
 
Puig, S.a.
 patent
where one patent can have more than one assignee

Years Active: 2007-2017

Loading Chart...
Loading Chart...
15 patents (USPTO):Explore Patents
1. 9771392 - Compounds which inhibit neuronal exocytosis (2017-09-26),
2. 9725483 - Compounds for the treatment and/or care of the skin and/or mucous membranes and their use in cosmetic or pharmaceutical compositions (2017-08-08),
3. RE46228 - Pigmentation-regulating compounds (2016-12-05),
4. 9511010 - Compounds useful in the treatment and/or care of the skin, hair and/or mucous membranes and their cosmetic or pharmaceutical compositions (2016-12-06),
5. 9464129 - Neuronal exocytosis inhibiting peptides (2016-10-11),
6. 9458194 - Compounds useful in the treatment and/or care of the skin and their cosmetic or pharmaceutical compositions (2016-10-04),
7. 9393187 - Peptide compounds that inhibit neuronal exocytosis (2016-07-19),
8. 9315564 - Cosmetic or pharmaceutical compositions comprising metalloproteinase inhibitors (2016-04-19),
9. 8993716 - Peptides used in the treatment and/or care of the skin, mucous membranes and/or hair and its use in cosmetic or pharmaceutical compositions (2015-03-31),
10. 8946166 - Peptide-based compounds and compositions which inhibit muscle contraction (2015-02-03),
11. 8815266 - Peptide derivatives useful in the treatment, care or cleansing of the skin, mucosae, scalp or nails (2014-08-26),
12. 8710011 - Cosmetic or pharmaceutical peptides containing uncoded amino acids and their use in the treatment and/or care of the skin, mucous membranes, or scalp (2014-04-29),
13. 8710010 - Peptides useful in the treatment and/or care of skin, mucous membranes, scalp and/or hair and their use in cosmetic or pharmaceutical compositions (2014-04-29),
14. 8110207 - Pigmentation-regulating compounds (2012-02-07),
15. 7183430 - Compounds which can block the response to chemical substances or thermal stimuli or mediators of inflammation of nociceptors, production method thereof and compositions containing same (2007-02-27),

Title: Cristina Carreño Serraïma: Innovator in Pharmaceutical Compounds

Introduction

Cristina Carreño Serraïma is a prominent inventor based in Barcelona, Spain. She has made significant contributions to the field of pharmaceutical compounds, holding a total of 13 patents. Her work focuses on innovative solutions for medical treatments, particularly in the areas of pain management and skin care.

Latest Patents

Among her latest patents are compounds that inhibit neuronal exocytosis. These compounds, described by the general formula (I): R-W-X-AA-AA-AA-AA-AA-AA-AA-AA-AA-Y-Z-R(I), include their stereoisomers, mixtures, and cosmetically or pharmaceutically acceptable salts. They are intended for use in medicine, specifically for treating and preventing pain, inflammation, itching, and various neurological and neuropsychiatric disorders. Another notable patent involves compounds for the treatment and care of the skin and mucous membranes, which also utilize the general formula (I). These compounds aim to address issues such as pigmentation disorders and angiogenic skin disorders.

Career Highlights

Cristina has worked with reputable companies such as Lipotec and Lubrizol Advanced Materials, Inc. Her experience in these organizations has allowed her to develop and refine her innovative ideas in the pharmaceutical sector.

Collaborations

Throughout her career, Cristina has collaborated with notable professionals, including Antonio Vicente Ferrer Montiel and Wim Van Den Nest. These partnerships have contributed to her success and the advancement of her research.

Conclusion

Cristina Carreño Serraïma stands out as a leading inventor in the pharmaceutical industry, with a focus on compounds that address critical medical needs. Her extensive patent portfolio and collaborative efforts highlight her commitment to innovation and improving health outcomes.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…